TNF Pharmaceuticals, Inc.
For the period ended Aug 28, 2025. Filed Sep 2, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 28, 2025 · Filed Sep 2, 2025
QCLS$0.34+2.7%Stored close · as of Nov 6, 2026
Contents
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.